Lyra Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Lyra Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2020 to Q2 2024.
  • Lyra Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -81.2 %, a 49.8% decline year-over-year.
  • Lyra Therapeutics, Inc. annual Return On Assets for 2023 was -51.9 %, a 4.43% increase from 2022.
  • Lyra Therapeutics, Inc. annual Return On Assets for 2022 was -54.4 %, a 15.1% increase from 2021.
  • Lyra Therapeutics, Inc. annual Return On Assets for 2021 was -64 %, a 118% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -81.2 -27 -49.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -52 +0.66 +1.26% Jan 1, 2024 Mar 31, 2024
Q4 2023 -51.9 +2.41 +4.43% Oct 1, 2023 Dec 31, 2023
Q3 2023 -54.9 +7.28 +11.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -54.2 +13.7 +20.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -52.6 +24.7 +32% Jan 1, 2023 Mar 31, 2023
Q4 2022 -54.4 +9.67 +15.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -62.2 -12.6 -25.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -67.9 -27.4 -67.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -77.3 -46.5 -151% Jan 1, 2022 Mar 31, 2022
Q4 2021 -64 -34.7 -118% Oct 1, 2021 Dec 31, 2021
Q3 2021 -49.6 -16.6 -50.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -40.6 Apr 1, 2021 Jun 30, 2021
Q1 2021 -30.8 Jan 1, 2021 Mar 31, 2021
Q4 2020 -29.3 Oct 1, 2020 Dec 31, 2020
Q3 2020 -33 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.